Table 3.
Proportion of subjects turned from H. pylori—positive (Hp+) to negative (Hp−) status as measured by HpSA and 13C-UBT.
| Groups | Days | n | HpSA | 13C-UBT | ||
|---|---|---|---|---|---|---|
| Hp+ | Hp− (%) | Hp+ | Hp− (%) | |||
| GutGard | 0 | 50 | 50 | 0 (0) | 50 | 0 (0) |
| Placebo | 50 | 50 | 0 (0) | 50 | 0 (0) | |
| GutGard | 30 | 50 | 50 | 0 (0) | 50 | 0 (0) |
| Placebo | 50 | 50 | 0 (0) | 50 | 0 (0) | |
| GutGard | 60 | 50 | 22 | 28* (56) | 26 | 24* (48) |
| Placebo | 50 | 48 | 2 (4) | 49 | 1 (2) | |
n: no. of subjects; Hp−: H. pylori negative; Hp+: H. pylori positive.
%: percentage of subjects turned from Hp Positive to Hp Negative.
*Significant difference compared to placebo.